PhaseBio Pharmaceuticals, Inc. (PHAS)


PhaseBio Pharmaceuticals, Inc. (PHAS)

$5.37 USD

0.24 (4.68%)

Updated Sep 13 12:00am

Add PHAS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

PHAS Daily Price Range
PHAS 52-Week Price Range

PHAS Stock Chart More Charts


PHAS Price/Volume Stats

Current price $5.37
Prev. close $5.13
Day low $5.08
Day high $5.44
50-day MA $8.37
200-day MA $7.76
52-week high $16.65
52-week low $2.55
Volume 270,200
Avg. volume 263,057
Dividend yield N/A
Market Cap 154.11M

PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.





PHAS News Stream


Event/Time News Detail
Loading, please wait...

PHAS Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Returns

1-mo -27.33%
3-mo -56.23%
6-mo -13.39%
1-year N/A
3-year N/A
5-year N/A
YTD 73.79%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4381 seconds.